You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Investigational Drug Information for Norketamine


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Norketamine?

Norketamine is an investigational drug.

There have been 11 clinical trials for Norketamine. The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2018.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Mucositis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), Bhupesh Parashar, MD, and Congressionally Directed Medical Research Programs.

There are twenty-six US patents protecting this investigational drug and one hundred and eight international patents.

Recent Clinical Trials for Norketamine
TitleSponsorPhase
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic PainCongressionally Directed Medical Research ProgramsPhase 1/Phase 2
(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic PainRush University Medical CenterPhase 1/Phase 2
Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage TrialBhupesh Parashar, MDPhase 2

See all Norketamine clinical trials

Clinical Trial Summary for Norketamine

Top disease conditions for Norketamine
Top clinical trial sponsors for Norketamine

See all Norketamine clinical trials

US Patents for Norketamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Norketamine ⤷  Try a Trial Ketamine derivatives Auckland Uniservices Limited (Auckland, NZ) ⤷  Try a Trial
Norketamine ⤷  Try a Trial Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods Amorsa Therapeutics, Inc. (Littleton, MA) ⤷  Try a Trial
Norketamine ⤷  Try a Trial Assay for methoxetamine Randox Laboratories Ltd. (GB) ⤷  Try a Trial
Norketamine ⤷  Try a Trial Oral dosage forms of ketamine Develco Pharma Schweiz AG (Pratteln, CH) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Norketamine

Drugname Country Document Number Estimated Expiration Related US Patent
Norketamine Australia AU2013328280 2032-10-08 ⤷  Try a Trial
Norketamine Brazil BR112015007647 2032-10-08 ⤷  Try a Trial
Norketamine Canada CA2922340 2032-10-08 ⤷  Try a Trial
Norketamine China CN104837810 2032-10-08 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.